Nifty

:

23270.60

Sensex

:

74314.59

53.00 (0.23%)
-21.86 (-0.03%)

Login

Nifty
Sensex

:
:

23270.60
74314.59

53.00 (0.23%)
-21.86 (-0.03%)

Blue Jet Healthcare Ltd.

Pharmaceuticals & Drugs

Rating :

65/99

BSE: 544009 | NSE: BLUEJET

Watchlist

NSE BSE

565.05

16-Sep-2026

Open
High
Low
Previous Close

553
575
543.75
550.65

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1113127
628649575.4
715.15
325

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

10,676.10
45.45
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

10,527.22
0.21%
4.77

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
6.75
10.01

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
3.36
5.11

PAT CAGR (%)

10 Years
5 Years
3 Years

-
6.42
14.81

P:E (Median)

8 Years
5 Years
3 Years

-
-
41.57

P:BV (Average)

8 Years
5 Years
3 Years

-
-
8.10

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
28.15

Earnings Forecasts:

(Updated: 12-09-2026)

Description 2026 2027 2028 2029
Adj EPS 37 -3 18.62 13.44
P/E Ratio 15.27 -188.35 30.35 42.04
Revenue 32.98 30.04 25.42 920.75
EBITDA 1107.26 1240.5 1552.3 286.7
Net Income 363.59 414.11 530.33 233.18
ROA 287.87 312.53 387.4 16.17
P/B Ratio -1.62 -1.22 -1.03 7.34
ROE 6.08 5.16 4.24 18.7
FCFF 18.79 17.41 18.2 45.16
FCFF Yield -108.22 21.16 50.57 0.47
Net Debt -1.14 0.22 0.53 -303.72
BVPS -349.42 -464.38 -550.55 76.93

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 293.11 354.76 -17.38% 234.67 340.44 -31.07% 192.41 318.38 -39.57% 165.48 208.26 -20.54%
Expenses 195.04 233.76 -16.56% 163.40 200.48 -18.50% 145.52 194.37 -25.13% 110.53 138.77 -20.35%
EBITDA 98.07 120.99 -18.94% 71.27 139.97 -49.08% 46.89 124.01 -62.19% 54.95 69.49 -20.92%
EBIDTM 33.46% 34.11% 30.37% 41.11% 24.37% 38.95% 33.21% 33.37%
Other Income 15.24 8.25 84.73% 22.92 12.22 87.56% 13.21 13.24 -0.23% 24.27 12.07 101.08%
Interest 0.66 0.69 -4.35% 0.58 0.03 1,833.33% 0.34 0.02 1,600.00% 4.63 0.02 23,050.00%
Depreciation 6.71 5.70 17.72% 6.46 4.95 30.51% 5.98 4.75 25.89% 5.87 4.62 27.06%
PBT 105.95 122.86 -13.76% 87.15 147.21 -40.80% 53.78 132.49 -59.41% 68.73 76.92 -10.65%
Tax 27.68 31.69 -12.65% 22.80 37.12 -38.58% 13.61 33.51 -59.39% 16.59 18.57 -10.66%
PAT 78.26 91.17 -14.16% 64.34 110.09 -41.56% 40.17 98.98 -59.42% 52.14 58.35 -10.64%
PATM 26.70% 25.70% 27.42% 32.34% 20.87% 31.09% 31.51% 28.02%
EPS 4.51 5.25 -14.10% 3.71 6.35 -41.57% 2.32 5.71 -59.37% 3.00 3.36 -10.71%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Net Sales 885.67 947.32 1,029.98 711.60 720.98 683.47 498.93 Net Sales Growth -27.51% -8.03% 44.74% -1.30% 5.49% 36.99% Cost Of Goods Sold 390.02 435.81 461.23 314.40 335.96 287.45 169.45 Gross Profit 495.65 511.51 568.76 397.20 385.02 396.01 329.48 GP Margin 55.96% 54.00% 55.22% 55.82% 53.40% 57.94% 66.04% Total Expenditure 614.49 653.22 652.25 482.37 501.89 434.20 292.08 Power & Fuel Cost - 25.95 24.84 24.56 32.99 27.25 19.91 % Of Sales - 2.74% 2.41% 3.45% 4.58% 3.99% 3.99% Employee Cost - 73.53 61.00 53.19 41.90 33.03 28.95 % Of Sales - 7.76% 5.92% 7.47% 5.81% 4.83% 5.80% Manufacturing Exp. - 47.48 43.53 34.21 35.44 37.89 33.14 % Of Sales - 5.01% 4.23% 4.81% 4.92% 5.54% 6.64% General & Admin Exp. - 15.38 12.18 8.90 6.72 5.23 8.11 % Of Sales - 1.62% 1.18% 1.25% 0.93% 0.77% 1.63% Selling & Distn. Exp. - 32.98 29.93 28.26 33.03 32.28 24.43 % Of Sales - 3.48% 2.91% 3.97% 4.58% 4.72% 4.90% Miscellaneous Exp. - 22.09 19.56 18.86 15.85 11.08 8.07 % Of Sales - 2.33% 1.90% 2.65% 2.20% 1.62% 1.62% EBITDA 271.18 294.10 377.73 229.23 219.09 249.27 206.85 EBITDA Margin 30.62% 31.05% 36.67% 32.21% 30.39% 36.47% 41.46% Other Income 75.64 68.65 46.26 28.86 23.96 19.41 8.61 Interest 6.21 6.24 0.10 0.16 1.36 3.30 5.31 Depreciation 25.02 24.00 17.79 28.09 25.07 22.15 19.66 PBT 315.61 332.51 406.10 229.84 216.61 243.23 190.49 Tax 80.68 84.70 100.90 56.34 56.58 61.64 48.87 Tax Rate 25.56% 25.47% 24.85% 25.60% 26.12% 25.34% 25.65% PAT 234.91 247.82 305.20 163.75 160.03 181.59 141.62 PAT before Minority Interest 234.91 247.82 305.20 163.75 160.03 181.59 141.62 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 26.52% 26.16% 29.63% 23.01% 22.20% 26.57% 28.38% PAT Growth -34.49% -18.80% 86.38% 2.32% -11.87% 28.22% EPS 13.54 14.28 17.59 9.44 9.22 10.47 8.16

Description TTM Mar 21 Mar 20
Net Sales - 498.93 538.20 Net Sales Growth - -7.30% Cost Of Goods Sold - 169.45 210.42 Gross Profit - 329.48 327.78 GP Margin - 66.04% 60.90% Total Expenditure - 292.88 324.47 Power & Fuel Cost - 19.91 19.30 % Of Sales - 3.99% 3.59% Employee Cost - 28.95 23.88 % Of Sales - 5.80% 4.44% Manufacturing Exp. - 33.14 29.21 % Of Sales - 6.64% 5.43% General & Admin Exp. - 8.11 6.98 % Of Sales - 1.63% 1.30% Selling & Distn. Exp. - 24.43 21.27 % Of Sales - 4.90% 3.95% Miscellaneous Exp. - 8.87 13.42 % Of Sales - 1.78% 2.49% EBITDA - 206.05 213.73 EBITDA Margin - 41.30% 39.71% Other Income - 8.88 5.81 Interest - 5.31 7.37 Depreciation - 19.66 18.04 PBT - 189.96 194.13 Tax - 48.87 49.17 Tax Rate - 26.47% 25.33% PAT - 138.42 144.85 PAT before Minority Interest - 135.79 144.96 Minority Interest - 2.63 -0.11 PAT Margin - 27.74% 26.91% PAT Growth - -4.44% EPS - 7.98 8.35

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 1,359.91 1,133.11 845.22 681.49 521.54 339.82 Share Capital 34.69 34.69 34.69 34.69 34.69 9.91 Total Reserves 1,325.22 1,098.42 810.53 646.79 486.85 329.91 Non-Current Liabilities 350.27 28.51 7.66 6.70 17.33 33.35 Secured Loans 0.00 0.00 0.00 0.00 0.00 28.67 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 302.06 4.70 4.12 4.13 3.77 3.29 Current Liabilities 276.66 500.57 361.59 318.42 259.07 220.05 Trade Payables 56.92 89.05 30.30 53.78 56.55 59.53 Other Current Liabilities 56.15 33.75 50.55 38.66 32.35 46.12 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 7.13 Short Term Provisions 163.59 377.77 280.74 225.98 170.17 107.27 Total Liabilities 1,986.84 1,662.19 1,214.47 1,006.61 797.94 593.22 Net Block 316.43 300.29 171.94 151.04 156.48 138.92 Gross Block 457.72 420.87 275.57 230.56 214.58 176.03 Accumulated Depreciation 141.29 120.58 103.63 79.52 58.10 37.11 Non Current Assets 980.60 411.58 353.21 197.02 165.03 146.25 Capital Work in Progress 301.38 89.16 147.06 30.46 3.43 2.58 Non Current Investment 25.18 0.00 15.00 0.00 0.00 0.00 Long Term Loans & Adv. 323.69 21.75 18.98 15.34 5.02 4.66 Other Non Current Assets 13.92 0.39 0.24 0.17 0.10 0.08 Current Assets 1,006.25 1,250.61 861.26 809.59 632.70 446.97 Current Investments 226.70 186.69 235.49 189.28 93.77 36.84 Inventories 187.39 263.92 129.84 125.66 105.03 117.72 Sundry Debtors 339.05 349.53 176.93 239.38 227.44 144.00 Cash & Bank 148.87 119.79 84.71 65.63 87.66 70.45 Other Current Assets 104.25 6.57 15.49 18.13 118.79 77.97 Short Term Loans & Adv. 86.47 324.11 218.81 171.52 110.58 73.77 Net Current Assets 729.59 750.04 499.67 491.17 373.63 226.93 Total Assets 1,986.85 1,662.19 1,214.47 1,006.61 797.73 593.22

Description Mar 21 Mar 20
Shareholder's Funds 339.82 201.42 Share Capital 9.91 0.60 Total Reserves 329.91 191.50 Non-Current Liabilities 33.35 37.87 Secured Loans 28.67 36.93 Unsecured Loans 0.00 0.00 Long Term Provisions 3.29 2.48 Current Liabilities 220.04 191.10 Trade Payables 59.53 52.01 Other Current Liabilities 46.11 58.63 Short Term Borrowings 7.13 17.84 Short Term Provisions 107.27 62.63 Total Liabilities 593.21 431.72 Net Block 138.92 107.16 Gross Block 176.03 125.26 Accumulated Depreciation 37.11 18.10 Non Current Assets 146.24 125.04 Capital Work in Progress 2.58 2.04 Non Current Investment 0.00 8.36 Long Term Loans & Adv. 4.66 7.40 Other Non Current Assets 0.08 0.09 Current Assets 446.97 306.67 Current Investments 36.84 25.33 Inventories 117.72 69.01 Sundry Debtors 144.00 118.49 Cash & Bank 70.45 15.23 Other Current Assets 77.97 4.43 Short Term Loans & Adv. 73.77 74.18 Net Current Assets 226.93 115.57 Total Assets 593.21 431.71

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity 334.15 45.76 241.26 141.56 146.42 134.61 PBT 332.51 406.10 220.09 216.61 243.23 190.49 Adjustment 1.44 -8.50 19.08 17.81 6.74 17.03 Changes in Working Capital 109.00 -262.80 13.17 -32.89 -75.96 -72.71 Cash after chg. in Working capital 442.95 134.80 252.34 201.53 174.00 134.81 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -108.81 -89.04 -11.08 -59.98 -27.59 -0.20 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -275.58 -35.18 -263.75 -147.25 -76.03 -56.03 Net Fixed Assets -249.07 -87.40 -161.61 -43.01 -39.40 Net Investments -65.19 63.80 -61.21 -95.51 -56.93 Others 38.68 -11.58 -40.93 -8.73 20.30 Cash from Financing Activity -30.69 -18.56 -1.99 -4.24 -56.15 -27.50 Net Cash Inflow / Outflow 27.88 -7.97 -24.48 -9.94 14.25 51.08 Opening Cash & Equivalents 32.98 40.95 65.44 75.37 61.13 10.05 Closing Cash & Equivalent 60.86 32.98 40.95 65.44 75.37 61.13

Description Mar 21
Cash From Operating Activity 129.28 PBT 184.66 Adjustment 17.55 Changes in Working Capital -72.73 Cash after chg. in Working capital 129.47 Interest Paid 0.00 Tax Paid -0.20 Other Direct Exp. Paid 0.00 Extra & Other Items 0.00 Cash From Investing Activity -50.73 Net Fixed Assets Net Investments Others Cash from Financing Activity -27.50 Net Cash Inflow / Outflow 51.05 Opening Cash & Equivalents 10.07 Closing Cash & Equivalent 61.13

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 78.40 65.32 48.73 39.29 30.07 19.59 ROA 13.58% 21.22% 14.75% 17.74% 26.11% 23.87% ROE 19.88% 30.85% 21.45% 26.60% 42.16% 41.67% ROCE 27.18% 41.06% 28.85% 36.24% 54.01% 50.03% Fixed Asset Turnover 2.16 2.96 2.81 3.24 3.50 2.83 Receivable days 132.65 93.28 106.77 118.17 99.18 105.35 Inventory Days 86.94 69.77 65.53 58.39 59.48 86.12 Payable days 61.13 47.23 48.81 59.93 73.70 128.23 Cash Conversion Cycle 158.47 115.82 123.49 116.62 84.96 63.23 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.15 Interest Cover 54.30 4144.87 1368.05 160.39 74.71 36.89

Description Mar 21
Book Value (Rs.) 19.59 ROA 26.50% ROE 51.06% ROCE 56.68% Fixed Asset Turnover 3.31 Receivable days 96.02 Inventory Days 68.30 Payable days 120.13 Cash Conversion Cycle 44.18 Total Debt/Equity 0.15 Interest Cover 35.79

Top Investors:

icici prudential pharma healthcare and diaganostics (p.h.d) fund

Annual Reports:

News Update:

Blue Jet Healthcare - Quarterly Results
4th Aug 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback